Vaccine targets malignant brain cancer antigens, significantly lengthens survival
Wednesday, August 15, 2012 - 09:00
in Health & Medicine
An experimental immune-based therapy more than doubled median survival of patients diagnosed with the most aggressive malignant brain tumor, researchers report.